Company enables efficient, cost-effective bioconversion of renewable feedstock
and , -- The Florida Institute for the Commercialization of Public Research (the Institute) announced today that it has finalized a funding agreement with BioTork, LLC, a Gainesville-based company with technology developed at the . The Institute supports new company creation based on publicly-funded research, and bridges early funding gaps for companies spinning out of Florida-based universities and research institutions.
BioTork is a strain development company specializing in the improvement of existing bioconversion processes, and the creation of new ones. With a focus on the microorganism factories, or the fermentation "software" rather than the industrial fermentation equipment or "hardware", the company can optimize any type of cell grown on any type of substrate under conditions that mimic industrial parameters. BioTork's technology can improve the fermentation capabilities of both GMO and non-GMO organisms, giving them the potential to enter markets that demand either or both approaches.
"BioTork is mastering the art of fermentation," said Eudes de Crecy, BioTork, LLC, Chief Executive Officer. "We can intervene in any market where a microorganism is used to manufacture the desired end-product, and achieve higher yields and shorter fermenter retention times to produce various commodities. Most importantly, we can use our technology to improve the robustness and performance of strains used for fermentation, which tend to be the greatest obstacles encountered in the industry."
"BioTork is forging a path to sustainable, green chemistry while improving industrial bioconversion processes," said , MD, Institute Chief Executive Officer. "Rather than using standardized approaches to solve diverse industrial challenges, the company is providing tailored microbial solutions that allow for greater efficiency and higher yields."
About the Institute